info [at] nonfiction.design
55 Grace Street, San Francisco, California
For roughly 1 in 3 patients with major depression, multiple medications fail to provide relief. These patients suffer from what is known as Treatment Resistant Depression (TRD). Fortunately, advances in brain science have revealed that rebalancing electrical activity may work when drugs fail.
Motif Neurotech's novel approach to combating depression uses a therapeutic BCI and miniature brain stimulator called DOT. By delivering specific stimulation patterns, or "motifs," DOT aims to rebalance brain activity, enabling patients to engage more effectively with the external world and experience relief from depressive symptoms.
The stimulator is implanted through a minimally invasive, 30-minute outpatient procedure. Once implanted, patients can receive prescribed therapy by simply wearing a hat that pairs with DOT. This design allows for treatment flexibility in various settings, enabling users to maintain their routines without disruption.
Nonfiction's design process is deeply informed by the experiences of those affected. Understanding the challenges of treatment-resistant depression (TRD), we recognize the importance of creating a solution that seamlessly integrates into daily life.
We engaged our design, strategy and fashion tech teams to ideate and create functional prototypes for proof-of-concept and human trials. By working closely with the scientists, engineers and patients to we are able to iterate quickly and uncover latent user needs.
Our aim is to create a discreet and comfortable accessory that users would feel confident incorporating into their daily attire. By prioritizing the needs and preferences of the end-users, we strive to ensure that the therapeutic process will be as unobtrusive and supportive as possible. Empathy through human-centered design translates directly to the aesthetics, comfort and ultimately the efficacy of the wearable.
%252520900x900px.jpeg)
Throughout the development, we maintained a collaborative relationship with Motif Neurotech, combining our design expertise with their technological innovations. This partnership allows us to create a product that not only addresses the clinical aspects of depression treatment but also resonates with users on a personal level.
For roughly 1 in 3 patients with major depression, multiple medications fail to provide relief. These patients suffer from what is known as Treatment Resistant Depression (TRD). Fortunately, advances in brain science have revealed that rebalancing electrical activity may work when drugs fail.
Motif Neurotech's novel approach to combating depression uses a therapeutic BCI and miniature brain stimulator called DOT. By delivering specific stimulation patterns, or "motifs," DOT aims to rebalance brain activity, enabling patients to engage more effectively with the external world and experience relief from depressive symptoms.
The stimulator is implanted through a minimally invasive, 30-minute outpatient procedure. Once implanted, patients can receive prescribed therapy by simply wearing a hat that pairs with DOT. This design allows for treatment flexibility in various settings, enabling users to maintain their routines without disruption.
Nonfiction's design process is deeply informed by the experiences of those affected. Understanding the challenges of treatment-resistant depression (TRD), we recognize the importance of creating a solution that seamlessly integrates into daily life.
We engaged our design, strategy and fashion tech teams to ideate and create functional prototypes for proof-of-concept and human trials. By working closely with the scientists, engineers and patients to we are able to iterate quickly and uncover latent user needs.
Our aim is to create a discreet and comfortable accessory that users would feel confident incorporating into their daily attire. By prioritizing the needs and preferences of the end-users, we strive to ensure that the therapeutic process will be as unobtrusive and supportive as possible. Empathy through human-centered design translates directly to the aesthetics, comfort and ultimately the efficacy of the wearable.
Throughout the development, we maintained a collaborative relationship with Motif Neurotech, combining our design expertise with their technological innovations. This partnership allows us to create a product that not only addresses the clinical aspects of depression treatment but also resonates with users on a personal level.
